Tiaki hires Bruhn as CEO for Alzheimer's drug discovery push

Tiaki Therapeutics has appointed Suzanne Bruhn as CEO. Bruhn, a serial biotech CEO, arrives at Tiaki shortly after the Alzheimer’s disease startup entered into a collaboration with Eisai.